Publication | Closed Access
Characterization of sialosylated Lewisx as a new tumor-associated antigen.
502
Citations
28
References
1984
Year
Lymphoid NeoplasiaImmunocytochemical TechniqueSialosylated LewisxSurgical PathologyImmunologyTumor ImmunityPathologyImmunochemistryAntibody EngineeringImmunotherapeuticsCslex1 EpitopeImmunotherapyMedicineCslex1 AntibodyTumor MicroenvironmentTumor BiologyMonoclonal Antibody Cslex1
A monoclonal antibody CSLEX1 which reacts with sialosyl Lex but not with sialosyl Lea has been produced. The CSLEX1 antigen has a tissue distribution similar to that of Lex, appearing characteristically in the proximal tubules of the kidney and on granulocytes. It is tumor associated in that 14 of 34 (41%) of tumor lines tested reacted with the CSLEX1 antibody, and 50 of 74 (68%) of tumor tissues tested reacted with the antibody. Loss of immunoperoxidase staining of tissues after neuraminidase treatment showed that the antibody is reacting to sialyl derivatives. The antibody reacted in solid-phase radioimmunoassay to sialosyllactofucopentaosyl(III)ceramide and sialosyldifucosylganglioside (6B). These results indicate that the CSLEX1 epitope has the following structure: (formula: see text) This structure had not previously been known to be tumor associated.
| Year | Citations | |
|---|---|---|
Page 1
Page 1